Driving Simulator Study Comparing Two Modes of Presbyopic Correction With Contact Lenses
Not Applicable
Completed
- Conditions
- Presbyopia
- Interventions
- Device: Lotrafilcon B MFDevice: Lotrafilcon B MVDevice: Lotrafilcon B SVDDevice: Comfilcon A MFDevice: Habitual contact lenses
- First Posted Date
- 2014-07-15
- Last Posted Date
- 2016-02-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 33
- Registration Number
- NCT02189863
Retrospective / Prospective Clinical Study of AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric Intraocular Lenses
Not Applicable
Completed
- Conditions
- PresbyopiaCorneal AstigmatismCataract
- Interventions
- Device: AcrySof® IQ ReSTOR® +2.5 D Multifocal Toric IOL
- First Posted Date
- 2014-06-27
- Last Posted Date
- 2018-07-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 37
- Registration Number
- NCT02176343
A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers
Not Applicable
Completed
- Conditions
- Myopia
- Interventions
- Device: Phemfilcon A contact lenses with color printingDevice: Lotrafilcon B contact lenses with color printing
- First Posted Date
- 2014-06-26
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 151
- Registration Number
- NCT02175199
DW Evaluation of Lotrafilcon B Lenses in a Modified Design
Not Applicable
Completed
- Conditions
- Myopia
- Interventions
- Device: Lotrafilcon B sphere contact lensesDevice: Lotrafilcon B sphere modified design contact lenses
- First Posted Date
- 2014-06-06
- Last Posted Date
- 2015-08-11
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 134
- Registration Number
- NCT02157909
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Ocular HypertensionGlaucoma
- Interventions
- Drug: Travoprost 0.004% ophthalmic solution TRAVATAN Z®Drug: Dose Level B / Brinzolamide 1% ophthalmic suspensionDrug: Brinzolamide 1% ophthalmic suspension AZOPT®Drug: Dose Level A / Brinzolamide 1% ophthalmic suspensionDrug: Dose Level C / Brinzolamide 1% ophthalmic suspensionDrug: Brinzolamide suspension vehicleDrug: Travoprost solution vehicle
- First Posted Date
- 2014-05-16
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 327
- Registration Number
- NCT02140060
Multifocal High ADD Contact Lens Proof of Concept Trial
Not Applicable
Completed
- Conditions
- Presbyopia
- Interventions
- Device: Lotrafilcon B multifocal contact lenses (new)Device: Lotrafilcon B multifocal contact lenses
- First Posted Date
- 2014-04-21
- Last Posted Date
- 2015-08-26
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 268
- Registration Number
- NCT02117544
Comparative Evaluation of Contact Lens Centering of DAILIES® AquaComfort Plus® Versus 1-DAY ACUVUE® MOIST® in Japan
Not Applicable
Completed
- Conditions
- MyopiaMyopic AstigmatismRefractive Error
- Interventions
- Device: Nelfilcon A contact lensesDevice: Etafilcon A contact lenses
- First Posted Date
- 2014-04-03
- Last Posted Date
- 2014-10-29
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 42
- Registration Number
- NCT02103309
On-Eye Evaluation of Contact Lens Axis Location
Not Applicable
Completed
- Conditions
- Refractive ErrorMyopiaAstigmatism
- Interventions
- Device: Delefilcon A toric contact lens T1Device: Delefilcon A toric contact lens T3Device: Delefilcon A toric contact lens T5Device: Delefilcon A toric contact lens T2Device: Delefilcon A toric contact lens T4Device: Delefilcon A toric contact lens T6
- First Posted Date
- 2014-04-01
- Last Posted Date
- 2014-05-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 50
- Registration Number
- NCT02100410
Tear Film Stability of DAILIES® AquaComfort Plus® Contact Lenses vs. MyDay® Daily Disposable Contact Lenses
Not Applicable
Completed
- Conditions
- Refractive Error
- Interventions
- Device: Nelfilcon A contact lensesDevice: Stenfilcon A contact lenses
- First Posted Date
- 2014-03-17
- Last Posted Date
- 2015-05-15
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 31
- Registration Number
- NCT02089191
- Locations
- 🇩🇪
Alcon Investigative Site, Jena, Germany
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
Phase 2
Completed
- Conditions
- Allergic Conjunctivitis
- Interventions
- Drug: AL-53817 VehicleDrug: AL-53817 Ophthalmic Solution, 0.1%Drug: AL-78843 Ophthalmic Solution, 0.03%Drug: Dexamethasone Ophthalmic Suspension, 0.1%
- First Posted Date
- 2014-03-06
- Last Posted Date
- 2015-08-24
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 224
- Registration Number
- NCT02079649
© Copyright 2025. All Rights Reserved by MedPath